Insights

Loading spinner
Gathering insights about CytomX Therapeutics

CytomX Therapeutics Tech Stack

CytomX Therapeutics uses 8 technology products and services including EY, MATLAB, Google Hosted Libraries, and more. Explore CytomX Therapeutics's tech stack below.

  • EY
    Accounting
  • MATLAB
    Advanced Analytics And Data Science
  • Google Hosted Libraries
    Content Delivery Network
  • Cybot
    Cookie Compliance
  • NetSuite
    E-commerce
  • ADP
    Human Resource Management System
  • MediaElement.js
    Video Players
  • Acquia Cloud Site Factory
    Web Hosting

Media & News

CytomX Therapeutics's Email Address Formats

CytomX Therapeutics uses at least 1 format(s):
CytomX Therapeutics Email FormatsExamplePercentage
FLast@cytomx.comJDoe@cytomx.com
88%
FiLast@cytomx.comJoDoe@cytomx.com
6%
First@cytomx.comJohn@cytomx.com
4%
First.Last@cytomx.comJohn.Doe@cytomx.com
2%

Frequently Asked Questions

Where is CytomX Therapeutics's headquarters located?

Minus sign iconPlus sign icon
CytomX Therapeutics's main headquarters is located at 151 Oyster Point Blvd, South San Francisco, CA 94080, US. The company has employees across 4 continents, including North AmericaAfricaEurope.

What is CytomX Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact CytomX Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CytomX Therapeutics's stock symbol?

Minus sign iconPlus sign icon
CytomX Therapeutics is a publicly traded company; the company's stock symbol is CTMX.

What is CytomX Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
CytomX Therapeutics's official website is cytomx.com and has social profiles on LinkedInCrunchbase.

What is CytomX Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
CytomX Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CytomX Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2025, CytomX Therapeutics has approximately 106 employees across 4 continents, including North AmericaAfricaEurope. Key team members include Chief Business Officer: N. G.Vice President Clinical Operations: K. D.Vice President Clinical Development: M. V.. Explore CytomX Therapeutics's employee directory with LeadIQ.

What industry does CytomX Therapeutics belong to?

Minus sign iconPlus sign icon
CytomX Therapeutics operates in the Biotechnology Research industry.

What technology does CytomX Therapeutics use?

Minus sign iconPlus sign icon
CytomX Therapeutics's tech stack includes EYMATLABGoogle Hosted LibrariesCybotNetSuiteADPMediaElement.jsAcquia Cloud Site Factory.

What is CytomX Therapeutics's email format?

Minus sign iconPlus sign icon
CytomX Therapeutics's email format typically follows the pattern of FLast@cytomx.com. Find more CytomX Therapeutics email formats with LeadIQ.

How much funding has CytomX Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2025, CytomX Therapeutics has raised $100M in funding. The last funding round occurred on May 12, 2025 for $100M.
CytomX Therapeutics

CytomX Therapeutics

Biotechnology ResearchUnited States51-200 Employees

CytomX Therapeutics, Inc. is committed to changing the treatment of cancer with our novel Probody® therapeutic platform. We have a broad pipeline comprised of five clinical-stage programs, with even more in development. 

Our commitment to transforming lives with safer, more effective therapies is driven by our curiosity and passion for innovation, and our belief that by acting with integrity in an honest, respectful, ethical manner, we have the power to change lives. Our workplace embodies collaboration, open communication, celebrating our successes and holding each other to the highest possible standards. 

CytomX embraces diversity and seeks to enhance and maintain our culture of equity and inclusion which encourages individuals to be themselves, feel involved, respected and connected.

We at CytomX believe that we benefit from each other’s ideas and experiences. We accept our differences and learn from one another, improve together, and embrace change to achieve our corporate and individual objectives. This belief applies to how we work together at CytomX, how we work with others outside CytomX, how we represent CytomX in our communities, and how we endeavor to bring our scientific innovations to a diverse patient population.

CytomX acknowledges the importance of diversity, equity and inclusion initiatives and that they require an evolving and ongoing commitment. CytomX is an equal opportunity employer and does not discriminate against any individual or potential candidate because of race, color, religion, sex, national origin, sexual preference or any other legally protected category.

CytomX is located in South San Francisco, California, the birthplace of biotechnology. Learn more about us and how we are advancing science to treat cancer differently at www.cytomX.com.

Section iconCompany Overview

Headquarters
151 Oyster Point Blvd, South San Francisco, CA 94080, US
Phone number
Website
cytomx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CTMX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $100M

    CytomX Therapeutics has raised a total of $100M of funding over 9 rounds. Their latest funding round was raised on May 12, 2025 in the amount of $100M.

  • $100M$250M

    CytomX Therapeutics's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M

    CytomX Therapeutics has raised a total of $100M of funding over 9 rounds. Their latest funding round was raised on May 12, 2025 in the amount of $100M.

  • $100M$250M

    CytomX Therapeutics's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.